Social Impact Report

Overview

The report describes Teva's 2016 social impact across access to affordable medicines, integration of 14,000 Actavis Generics colleagues, employee diversity and safety, community support, and environmental improvements. It reports a 15% reduction in the global recordable injury rate and an 11% reduction in Scope 1 and 2 greenhouse gas emissions. The report is prepared in accordance with the GRI Standards and fulfills Teva's annual Communication on Progress to the United Nations Global Compact.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2016
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services